To determine the clinical features of a Guillain-Barré syndrome variant with prominent facial diplegia, we retrospectively reviewed approximately 8,600 cases referred to our neuroimmunological laboratory for serological tests during the past seven years. Patients’ histories, neurological signs, and laboratory and electrophysiological data were clarified based on their clinical records. Sera obtained during the acute phase were tested for prior infectious serology and anti-ganglioside antibodies. In 22 patients, clinical signs such as acute progressive bifacial weakness, paresthesias in the distal dominant limbs, and hypo- or areflexia, were compatible with a Guillain-Barré syndrome variant, facial diplegia and paresthesias. Other cranial nerve involvements, limb weakness, and ataxia were absent or minimal. Clinical courses were monophasic, the nadir being reached within four weeks. Eighteen patients (86%) had had infectious symptoms within the four weeks preceding the onset of neurological illness. In the infection serology tests, anti-cytomegalovirus IgM antibodies were the most frequent (35%). All the patients had cerebrospinal fluid albuminocytologic dissociation. In nerve conduction studies, 14 (64%) showed demyelination in their limbs. Anti-GM2 IgM antibodies were detected in four patients who had anti-cytomegalovirus IgM antibodies. Patients with conditions similar to facial diplegia and paresthesias, but lacking either distal paresthesias or hyporeflexia, were regarded as having marginal facial diplegia and paresthesias, because they also frequently had features of Guillain-Barré syndrome, such as an antecedent infection or cerebrospinal fluid albuminocytologic dissociation. Our findings are further evidence of a facial variant of Guillain-Barré syndrome and provide important information essential for its diagnosis.
This is a preview of subscription content, log in to check access.
We thank Ms. Y. Tamura and M. Okazaki (Department of Neurology, Dokkyo Medical University, Tochigi, Japan) for their technical assistance.
Conflict of interest statement
The authors report no conflicts of interest.
Ang CW, Jacobs BC, Brandenburg AH, Laman JD, van der Meché FGA, Osterhaus AD et al (2000) Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome. Neurology 54:1453–1458PubMedGoogle Scholar
Atsumi M, Kitaguchi M, Nishikawa S, Susuki K (2004) A variant of Guillain-Barré syndrome with prominent bilateral peripheral facial nerve palsy: facial diplegia and paresthesias. Rinsho Shinkeigaku 44:549–552PubMedGoogle Scholar
Charous DI, Saxe BI (1962) The Landry-Guillain-Barré syndrome: report of an unusual case, with a comment on Bell’s palsy. N Engl J Med 267:1334–1338PubMedCrossRefGoogle Scholar
Galassi G, Susuki K, Quaglino D, Yuki N (2004) Post-infectious acute ataxia and facial diplegia associated with anti-GD1a IgG antibody. Eur J Neurol 11:790–791CrossRefPubMedGoogle Scholar
Hiraga A, Kuwabara S, Ogawara K, Misawa S, Kanesaka T, Koga M et al (2005) Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome. Neurology 64:856–860PubMedGoogle Scholar
Hozumi A, Yuki N, Yamazaki K, Hirata K (1999) Facial diplegia with paraesthesias: facial nerve enhancement in three dimensional MRI. J Neurol Neurosurg Psychiatry 66:688CrossRefPubMedGoogle Scholar
Keane JR (1994) Bilateral seventh nerve palsy: analysis of 43 cases and review of the literature. Neurology 44:1198–1202PubMedGoogle Scholar
Koga M, Yuki N, Tai T, Hirata K (2001) Miller Fisher syndrome and Haemophilus influenzae infection. Neurology 57:686–691PubMedGoogle Scholar
Koga M, Gilbert M, Li J, Koike S, Takahashi M, Furukawa K et al (2005) Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology 64:1605–1611CrossRefPubMedGoogle Scholar
Kuwabara S, Ogawara K, Koga M, Mori M, Hattori T, Yuki N (1999) Hyperreflexia in Guillain-Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody. J Neurol Neurosurg Psychiatry 67:180–184CrossRefPubMedGoogle Scholar
Odaka M, Yuki N, Nishimoto Y, Hirata K (2002) Guillain-Barré syndrome presenting with loss of taste. Neurology 58:1437–1438PubMedGoogle Scholar
Peitersen E (2002) Bell’s palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol 549(suppl):4–30Google Scholar
Ropper AH (1994) Further regional variants of acute immune polyneuropathy. Arch Neurol 51:671–675PubMedGoogle Scholar
Said G, Lacroix C, Planté-Bordeneuve V, Le Page L, Pico F, Presles O et al (2002) Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: a clinicopathological study of 11 patients. Brain 125:264–275CrossRefPubMedGoogle Scholar
Sethi NK, Torgovnick J, Arsura E, Johnston A, Buescher E (2007) Facial diplegia with hyperreflexia -a mild Guillain-Barré syndrome variant, to treat or not to treat? J Brachial Plex Peripher Nerve Inj 2:9CrossRefPubMedGoogle Scholar
Shuaib A, Becker WJ (1987) Variants of Guillain-Barré syndrome: Miller Fisher syndrome, facial diplegia and multiple cranial nerve palsies. Can J Neurol Sci 14:611–616PubMedGoogle Scholar
Susuki K, Atsumi M, Koga M, Hirata K, Yuki N (2004) Acute facial diplegia and hyperreflexia: a Guillain-Barré syndrome variant. Neurology 62:825–827PubMedGoogle Scholar
Takiyama Y, Sato Y, Sawada M, Nishizawa M, Nakano I, Kusunoki S (1999) An unusual case of facial diplegia. Muscle Nerve 22:778–779CrossRefPubMedGoogle Scholar
Tan EK, Lim SH, Wong MC, Chan LL (1999) Facial diplegia: cranial variant of Guillain-Barré syndrome? J R Soc Med 92:26–27PubMedGoogle Scholar
Visser LH, van der Meché FGA, Meulstee J, Rothbarth PP, Jacobs BC, Schmitz PI et al (1996) Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Neurology 47:668–673PubMedGoogle Scholar
Yuki N, Tagawa Y, Irie F, Hirabayashi Y, Handa S (1997) Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1α. J Neuroimmunol 74:30–34CrossRefPubMedGoogle Scholar